DUBLIN--(BUSINESS WIRE)--The "Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Inhalation and ...
DEAR DR. ROACH: I am a 73-year-old male with chronic obstructive pulmonary disease (COPD). I pretty much have it under control with medication, but I am still not able to do a whole lot, as I feel ...
The U.S. Food and Drug Administration approved Striverdi Respimat (olodaterol), an inhalation spray drug aimed at treating patients with chronic obstructive pulmonary disease. Striverdi Respimat is a ...
Collaboration combines Flurry’s leading spray drying innovation with Experic’s GMP manufacturing to accelerate next-generation inhaled and nasal therapeutics. CRANBURY, N.J., March 24, 2026--(BUSINESS ...
Stiolto Respimat (tiotropium bromide and olodaterol) is a brand-name inhalation spray prescribed for chronic obstructive pulmonary disease (COPD) in adults. Stiolto Respimat can cause side effects, ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l62c4c/inhalation_and) has announced the addition of the "Inhalation & Nasal ...
Dear Dr. Roach: I am a 73-year-old male with chronic obstructive pulmonary disease (COPD). I pretty much have it under control with medication, but I am still not able to do a whole lot, as I feel ...
Collaboration combines Flurry’s leading spray drying innovation with Experic’s GMP manufacturing to accelerate next-generation inhaled and nasal therapeutics. Under the collaboration, Flurry will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results